These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 24500660)

  • 21. Evolutionary biology and development model of medicines: A necessary 'pas de deux' for future successful bacteriophage therapy.
    Froissart R; Brives C
    J Evol Biol; 2021 Dec; 34(12):1855-1866. PubMed ID: 34288190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacteriophages as potential new therapeutics to replace or supplement antibiotics.
    Kutateladze M; Adamia R
    Trends Biotechnol; 2010 Dec; 28(12):591-5. PubMed ID: 20810181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. History of Early Bacteriophage Research and Emergence of Key Concepts in Virology.
    Letarov AV
    Biochemistry (Mosc); 2020 Sep; 85(9):1093-1010. PubMed ID: 33050848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bacteriophage therapy: a regulatory perspective.
    Pelfrene E; Willebrand E; Cavaleiro Sanches A; Sebris Z; Cavaleri M
    J Antimicrob Chemother; 2016 Aug; 71(8):2071-4. PubMed ID: 27068400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bacteriophage therapy for the treatment of infections.
    Górski A; Miedzybrodzki R; Borysowski J; Weber-Dabrowska B; Lobocka M; Fortuna W; Letkiewicz S; Zimecki M; Filby G
    Curr Opin Investig Drugs; 2009 Aug; 10(8):766-74. PubMed ID: 19649921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hurdles in bacteriophage therapy: deconstructing the parameters.
    Tsonos J; Vandenheuvel D; Briers Y; De Greve H; Hernalsteens JP; Lavigne R
    Vet Microbiol; 2014 Jul; 171(3-4):460-9. PubMed ID: 24315040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bacteriophages as twenty-first century antibacterial tools for food and medicine.
    Maura D; Debarbieux L
    Appl Microbiol Biotechnol; 2011 May; 90(3):851-9. PubMed ID: 21491205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bacteriophages as Therapeutic Preparations: What Restricts Their Application in Medicine.
    Vlassov VV; Tikunova NV; Morozova VV
    Biochemistry (Mosc); 2020 Nov; 85(11):1350-1361. PubMed ID: 33280578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bacteriophage therapy.
    Sulakvelidze A; Alavidze Z; Morris JG
    Antimicrob Agents Chemother; 2001 Mar; 45(3):649-59. PubMed ID: 11181338
    [No Abstract]   [Full Text] [Related]  

  • 30. Bacteriophages as Therapeutic Agents: Alternatives to Antibiotics.
    Samir S
    Recent Pat Biotechnol; 2021; 15(1):25-33. PubMed ID: 33475081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bacteriophages for ESKAPE: role in pathogenicity and measures of control.
    Patil A; Banerji R; Kanojiya P; Koratkar S; Saroj S
    Expert Rev Anti Infect Ther; 2021 Jul; 19(7):845-865. PubMed ID: 33261536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality and safety requirements for sustainable phage therapy products.
    Pirnay JP; Blasdel BG; Bretaudeau L; Buckling A; Chanishvili N; Clark JR; Corte-Real S; Debarbieux L; Dublanchet A; De Vos D; Gabard J; Garcia M; Goderdzishvili M; Górski A; Hardcastle J; Huys I; Kutter E; Lavigne R; Merabishvili M; Olchawa E; Parikka KJ; Patey O; Pouilot F; Resch G; Rohde C; Scheres J; Skurnik M; Vaneechoutte M; Van Parys L; Verbeken G; Zizi M; Van den Eede G
    Pharm Res; 2015 Jul; 32(7):2173-9. PubMed ID: 25585954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bacteriophage therapy for human musculoskeletal and skin/soft tissue infections.
    Metsemakers WJ; Onsea J; Moriarty TF; Pruidze N; Nadareishvili L; Dadiani M; Kutateladze M
    Clin Microbiol Infect; 2023 Jun; 29(6):695-701. PubMed ID: 36669559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Towards Inhaled Phage Therapy in Western Europe.
    Wienhold SM; Lienau J; Witzenrath M
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30909579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Back to the future: bacteriophages as promising therapeutic tools.
    Domingo-Calap P; Georgel P; Bahram S
    HLA; 2016 Mar; 87(3):133-40. PubMed ID: 26891965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alternatives to Conventional Antibiotics in the Era of Antimicrobial Resistance.
    Ghosh C; Sarkar P; Issa R; Haldar J
    Trends Microbiol; 2019 Apr; 27(4):323-338. PubMed ID: 30683453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phage therapy: delivering on the promise.
    Harper DR; Anderson J; Enright MC
    Ther Deliv; 2011 Jul; 2(7):935-47. PubMed ID: 22833904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Bacteriophage therapy].
    Huovinen P
    Duodecim; 2003; 119(7):581-3. PubMed ID: 12762197
    [No Abstract]   [Full Text] [Related]  

  • 39. Bacteriophage Production in Compliance with Regulatory Requirements.
    Pirnay JP; Merabishvili M; Van Raemdonck H; De Vos D; Verbeken G
    Methods Mol Biol; 2018; 1693():233-252. PubMed ID: 29119444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implications of Bacteriophage- and Bacteriophage Component-Based Therapies for the Clinical Microbiology Laboratory.
    Caflisch KM; Patel R
    J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31092596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.